Back

Racial and ethnic disparities in the incidence of stroke and mortality in atrial fibrillation: a US nationwide study

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation: what is associated with mortality? Stroke in Atrial Fibrillation ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Utibe Essien

David Geffen School of Medicine at UCLA, Los Angeles (United States of America)

7 More presentations in this session

Presentation thumbnail
Comorbidities and risk of death in atrial fibrillation: a nationwide cohort study
Doctor A. Aro (Helsinki, FI)
Abstract Slides Video
Presentation thumbnail
Cognitive patterns according to mini-mental state examination domains in patients with AF and association with all-cause mortality: a cluster analysis from a contemporary prospective study
Doctor M. Vitolo (Modena, IT)
Abstract Slides Video
Presentation thumbnail
A 3-year retrospective exploration of predictors for cardiac arrest in atrial fibrillation
Doctor A. Brgdar (Washington, US)
Abstract Slides Video
Presentation thumbnail
Screening for Atrial Fibrillation (AF) by handheld single-lead ECG and risk of all-cause mortality stratified by non-AF cardiovascular disease
Doctor W. Sun (Shatin, HK)
Abstract Slides Video
Presentation thumbnail
The gender difference in cause of death in Japanese atrial fibrillation patients: The Fushimi AF Registry
Doctor K. Doi (Kyoto, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation: what is associated with mortality?

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
The impact of ethnicity on clinical outcomes in patients with heart failure and atrial fibrillation
thumbnail
Congress Presentation
Evolving trends in stroke prevention with focus on atrial fibrillation: ethnic and sex differences
thumbnail
Congress Presentation
Gender and racial differences in outcomes among patients with NVAF treated with oral anticoagulants: a real-world evaluation of Medicare beneficiaries

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources